These sources, listed in no particular order, support the claims made in various Eko marketing materials.
| Claim | Source |
|---|---|
| Providers who use Eko are 2x more likely to detect heart disease. | Rancier, M. A., Israel, I., Monickam, V., Prince, J., Verschoore, B., & Currie, C. (2023). Real World Evaluation of an Artificial Intelligence Enabled Digital Stethoscope for Detecting Undiagnosed Valvular Heart Disease in Primary Care. Circulation, 148, A13244. |
| Over 60% of heart diseases go undiagnosed. | Gardezi SKM, SENN O, Hunziker L, et al. Cardiac auscultation in diagnosing valvular heart disease: a comparison between general practitioners and cardiologists. Eur Heart J. 2017;38:1155. |
| Heart disease claims a life every 34 seconds. | Heart Disease Facts, Centers for Disease Control and Prevention. |
| 2 out of 3 clinicians are using AI to better enable patient care. | Albert Henry, Tanya. 2 in 3 Physicians Are Using Health AI-up 78% from 2023, American Medical Association, 26 Feb. 2025. |
| Experience 8x sound improvement over traditional stethoscopes. | Eko data on file. |
| Eko detects Low EF with 85% sensitivity and 70% specificity. | Bachtiger P, Petri CF, Scott FE et al. (2022). Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study. The Lancet Digital Health. |
| Eko detects AFib with 99% sensitivity and 97% specificity. | Eko Health, Inc. (2022). Artificial Intelligence Validation White Paper. |